Immunohistochemistry (IHC) Market Size, Share, Analysis, Trends, Growth, 2032

Immunohistochemistry (IHC) Market Insights

Zion Market Research has published a report on the global Immunohistochemistry (IHC) Market, estimating its value at USD 2.49 Billion in 2023, with projections indicating that it will reach USD 4.37 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.8% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Immunohistochemistry (IHC) Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

The report offers an assessment and analysis of the Immunohistochemistry (IHC) market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion).

Immunohistochemistry (IHC) Market: Overview

Immunohistochemistry or IHC is a technique that makes effective use of monoclonal & polyclonal antibodies for identifying particular kinds of antigens in tissues, thereby identifying various types of diseases in the person. The IHC technique is divided into two phases: i) preparation of slides & stages involved in the reaction and ii) interpreting & quantifying the gene expression that is derived. Additionally, Immunohistochemistry plays a pivotal role in scientific research activities and the interpretation of differential diagnoses that cannot be determined through conventional analysis with the help of eosin and hematoxylin. It is also utilized in pathology, majorly in domains of pathology including hematopathology, oncologic pathology, and neuropathology. Furthermore, Immunohistochemistry is the combination of immunology & histology.

Immunohistochemistry (IHC) Market: Growth Factors

The surge in the occurrence of chronic ailments and a rise in drug discovery activities will manifest in the humungous growth of the immunohistochemistry (IHC) industry over 2024 – 2032. Apart from this, massive need for diagnosing cancer, heart disorders, and other viral ailments such as Swine Flu, Bird Flu, and COVID has unleashed the significance of immunohistochemistry in healthcare, thereby driving market trends. In addition to this, regulatory approvals as well as the launching of new products will steer the expansion of the immunohistochemistry (IHC) industry over the assessment timeline. Nonetheless, huge costs of automated IHC devices can badly hit the expansion of the market over the assessment timespan. However, a paradigm shift in the healthcare sector will drastically transform & turn the phase of market growth in the near future.

Furthermore, the rise in the diagnostic units and clinics along with the rise in the cases of life-threatening ailments will prop up the expansion of the immunohistochemistry (IHC) market over 2024 – 2032. The surge in cancer cases as well as the bulging elderly population prone to chronic ailments will help the market explore new dimensions of growth in the foreseeable future.

Request Free Sample

Immunohistochemistry (IHC) Market: Report Scope

Immunohistochemistry (IHC) Market:? Regional Landscape

Asia Pacific Market To Exude Fastest Growth Over 2024 – 2032

Untapped growth potential in the emerging economies of the Asia Pacific zone will help the Immunohistochemistry (IHC) market enter a new phase of growth in the coming years. The surge in chronic disorders in India, South Korea, Bangladesh, China, Singapore, and the Philippines has contributed immensely towards regional market size in recent years. Population explosion and surge in the geriatric population in the countries like India and China will proliferate the regional market expansion over the assessment period.

Immunohistochemistry (IHC) Market: Competitive Landscape

Key players profiled in the study are 

• Perkinelmer, Inc.
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Cell Signaling Technology, Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Bio SB
• Abcam plc. 

The global Immunohistochemistry (IHC) Market is segmented as follows:

By Product

• Antibodies
• Kits
• REAGENTS

By End-User

• Hospitals
• Academic
• Diagnostic Labs

By Application

• Forensic
• Diagnostic
• Research

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa